0001104659-23-082722.txt : 20230720 0001104659-23-082722.hdr.sgml : 20230720 20230720161551 ACCESSION NUMBER: 0001104659-23-082722 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230718 FILED AS OF DATE: 20230720 DATE AS OF CHANGE: 20230720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Happel David CENTRAL INDEX KEY: 0001623567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41742 FILM NUMBER: 231099883 MAIL ADDRESS: STREET 1: 7 HAMILTON LANDING STREET 2: SUITE 100 CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sagimet Biosciences Inc. CENTRAL INDEX KEY: 0001400118 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205991472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 155 BOVET RD., SUITE 303 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (650) 561-8600 MAIL ADDRESS: STREET 1: 155 BOVET RD., SUITE 303 CITY: SAN MATEO STATE: CA ZIP: 94402 FORMER COMPANY: FORMER CONFORMED NAME: 3-V Biosciences, Inc. DATE OF NAME CHANGE: 20070521 4 1 tm2321276-14_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-07-18 0 0001400118 Sagimet Biosciences Inc. SGMT 0001623567 Happel David SAGIMET BIOSCIENCES INC. 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 1 1 0 0 President & CEO 0 Stock Option (Right to Buy) 7.15 2023-07-18 4 D 0 1011826 0 D 2032-10-16 Common Stock 1011826 0 D Stock Option (Right to Buy) 7.15 2023-07-18 4 A 0 1011826 0 A 2032-10-16 Series A Common Stock 1011826 1011826 D Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock. 25% of the shares underlying this option shall vest and become exercisable on October 17, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. /s/ Dennis Hom, Attorney-in-Fact 2023-07-20